Menu

Numinus Appoints Michael Tan as CEO

Tan succeeds Payton Nyquvest, who will transition to the role of executive chair.

Numinus Wellness, a provider of psychedelic-assisted therapy in Canada and Utah, said it has appointed Michael Tan as CEO.

Tan succeeds Payton Nyquvest, who will transition to the role of executive chair.

Tan Michael joined Numinus as chief operating officer in 2019, prior to its initial listing, and added the role of president to his responsibilities in 2022. Over the years, he has overseen the company’s operations, M&A activities and organizational realignments.

“In his new role, [Tan] will prioritize strengthening Numinus’ clinical research and practitioner-training programs while aligning the company’s focus to better address emerging opportunities in mental health care,” the company said in a news release.

Before joining Numinus, Tan held senior-leadership positions at organizations including the BC Liquor Distribution Branch, Hudson’s Bay, Saks Fifth Avenue and UPS.

“I am committed to leading Numinus forward and pursuing opportunities for growth where we can create meaningful impact,” Tan said in a news release. “Our efforts will remain focused on advancing the areas of the business that show the most promise.”

In his new role as executive chair,  Nyquvest will continue to play an active role in the company, focusing on informing on corporate strategy, investor relations and strategic partnerships, according to Numinus.

“As a pioneer in the psychedelic-therapy sector, Numinus will benefit from his extensive experience, network and corporate-finance acumen,” the company added.

Numinus also announced that Allen Morishita has resigned from its board of directors. Morishita had served on the board since the company’s inception.